PHIO vs MSFT: Which Stock is Better?
Side-by-side comparison of Phio Pharmaceuticals Corp and Microsoft Corp in 2026
PHIO
Phio Pharmaceuticals Corp
$1.29
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | PHIO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $14.99M | N/A | PHIO |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze PHIO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHIO or MSFT a better investment?
Comparing PHIO and MSFT: Phio Pharmaceuticals Corp has a market cap of $14.99M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHIO and MSFT?
PHIO (Phio Pharmaceuticals Corp) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHIO or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHIO or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for PHIO.
Which company is more profitable: PHIO or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for PHIO.
Which is the larger company: PHIO or MSFT?
Phio Pharmaceuticals Corp (PHIO) is larger with a market cap of $14.99M compared to N/A for MSFT.
Should I buy PHIO or MSFT in 2026?
Both PHIO and MSFT have investment merit. PHIO trades at $1.29 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHIO and MSFT stock?
Key differences: Market Cap ($14.99M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).